Can Comprehensive Genomic Profiling Be Done in 24 Hours?
Research demonstrates an automated next-generation sequencing workflow designed to reduce hands-on time while delivering next-day CGP results.
Read MorePosted by Alyx Arnett | Feb 27, 2026 | Sequencing Systems |
Research demonstrates an automated next-generation sequencing workflow designed to reduce hands-on time while delivering next-day CGP results.
Read MorePosted by CLP Edit Staff | Feb 26, 2026 | Prostate |
Veracyte will present over 15 studies on its Decipher prostate and bladder cancer tests, including new clinical trial data, at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco.
Read MorePosted by CLP Edit Staff | Feb 9, 2026 | Cancer |
Hims & Hers Health is now offering GRAIL’s Galleri multi-cancer blood test through its digital health platform, expanding access to screening for more than 50 cancer types, including those lacking established protocols.
Read MorePosted by CLP Edit Staff | Feb 9, 2026 | Cancer |
Johns Hopkins researchers have developed a liquid biopsy that detects early-stage lung and breast cancers by measuring DNA methylation variation, showing high accuracy in a study published in Clinical Cancer Research.
Read MorePosted by CLP Edit Staff | Feb 2, 2026 | Cancer |
GRAIL has submitted an FDA premarket approval application for its Galleri multi-cancer early detection test, supported by data from more than 25,000 participants in US and UK clinical trials.
Read More